Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Australia

Australia Articles

Industry

Boosting Australia's reputation for high quality biomedical R&D, the Therapeutic Goods Administration (TGA) has approved local firm CSL's avian influenza vaccine, Panvax. Launch... 2008-06-20


Industry

Australian pharmaceutical and healthcare company Sigma Pharmaceuticals is concentrating on high-margin products to maintain financial health in an increasingly challenging operating... 2008-03-26


Industry

Reinforcing its position as one of Australia's leading drugmakers, Sigma Pharmaceuticals has acquired compatriot firm Orphan Holdings. The AUD130mn (US$113mn) deal gives Sigma an... 2007-12-24


More ARTICLES

Companies

In a blow to efficiency and a victory for nationalism, plans for a combined Australia/New Zealand agency for the approval of medicines have been deferred until there is more support... 2007-07-17


Companies

UK-based drugmaker GlaxoSmithKline (GSK)'s cervical cancer vaccine Cervarix has been approved in Australia, its first major market. This news is a bright note for GSK after the... 2007-05-23


Companies

Creating a world class antibody powerhouse, the Australian biotechnology firms Peptech and EvoGenix are to merge in an AUD156mn (US$130mn) deal. BMI is expecting great things from... 2007-05-15


Companies

Australian biotechnology firm Biota has increased its damages claim against UK-based multinational GlaxoSmithKline, alleging that its senior development partner for its influenza... 2007-04-02


Companies

Pharmaceuticals and biotechnology firms have outperformed other industries in Australia in terms of share price in the past 21 years, according to analysis from research firm

2007-01-11